Physician

Kiley Toder, M.D.

According to 2025 Medicare claims, Kiley Toder, M.D. (NPI: 1063640225) practices rheumatology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Providence, RI. This provider's primary affiliated billing organization is TODER RHEUMATOLOGY & OSTEOPOROSIS CENTER, P.C. (NPI: 1609272376; TIN: 472146775) and primary practice location at 02919-3228.

Toder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 365 traditional Medicare patients, billed 154,655 HCPCS/CPT codes, and received $1,522,476 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,592 prescription claims across 452 beneficiaries totaling $2,459,417 in drug costs, led by Enbrel Sureclick (Etanercept). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,500 to $1,522,476. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,185 to $2,459,417. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$761K$1.5M2015 Medicare payment: $9,500 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $24,729 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $29,195 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $85,967 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $123,761 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $339,838 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $407,560 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $521,814 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,287,564 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,522,476 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201552127$9,500
2016115482$24,729
20171311,106$29,195
20181234,610$85,967
20191498,415$123,761
202017825,034$339,838
202119736,237$407,560
202225848,021$521,814
2023365122,969$1,287,564
2024365154,655$1,522,476

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.5M2015 Drug cost: $19,185 (USD; Tot_Drug_Cst)2016 Drug cost: $74,532 (USD; Tot_Drug_Cst)2017 Drug cost: $44,620 (USD; Tot_Drug_Cst)2018 Drug cost: $176,185 (USD; Tot_Drug_Cst)2019 Drug cost: $258,774 (USD; Tot_Drug_Cst)2020 Drug cost: $285,405 (USD; Tot_Drug_Cst)2021 Drug cost: $457,169 (USD; Tot_Drug_Cst)2022 Drug cost: $724,165 (USD; Tot_Drug_Cst)2023 Drug cost: $1,566,430 (USD; Tot_Drug_Cst)2024 Drug cost: $2,459,417 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201524102$19,185
201665376$74,532
201792457$44,620
201891471$176,185
2019100586$258,774
2020107574$285,405
2021113614$457,169
2022173751$724,165
20233401,599$1,566,430
20244522,592$2,459,417

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less72423$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more218349$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more240451$68
J0897Injection, denosumab, 1 mg746,300$21
96372Injection of drug or substance under skin or into muscle79150$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept922,578$700,266
XeljanzTofacitinib Citrate792,430$457,929
Humira(Cf) PenAdalimumab591,672$433,065
Enbrel MiniEtanercept23644$189,264
ActemraTocilizumab29812$158,232

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Kiley Toder, M.D.?

Tedicare shows public-source Medicare data for Kiley Toder, M.D. (NPI 1063640225), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kiley Toder, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kiley Toder, M.D.?

Kiley Toder, M.D. is linked to TODER RHEUMATOLOGY & OSTEOPOROSIS CENTER, P.C. (billing NPI 1609272376) in the available physician profile data.

Does Kiley Toder, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.